148 related articles for article (PubMed ID: 32034698)
41. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Van Holm W; Verspecht T; Carvalho R; Bernaerts K; Boon N; Zayed N; Teughels W
Mol Oral Microbiol; 2022 Dec; 37(6):266-275. PubMed ID: 36075698
[TBL] [Abstract][Full Text] [Related]
42. In vivo prophylactic efficacy of Lactobacillus reuteri MT180537 against aerobic vaginitis.
Shazadi K; Ahmad SZ; Ahmad SS; Arshad N
Microb Pathog; 2021 Nov; 160():105197. PubMed ID: 34547410
[TBL] [Abstract][Full Text] [Related]
43.
Hu MX; He F; Guo YX; Mo LZ; Zhu X
J Agric Food Chem; 2022 Sep; 70(38):11935-11943. PubMed ID: 36111836
[TBL] [Abstract][Full Text] [Related]
44. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
45. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations.
Juárez Tomás MS; De Gregorio PR; Leccese Terraf MC; Nader-Macías ME
Eur J Pharm Sci; 2015 Nov; 79():87-95. PubMed ID: 26299342
[TBL] [Abstract][Full Text] [Related]
46. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells.
Karaçam S; Tunçer S
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):995-1011. PubMed ID: 34080175
[TBL] [Abstract][Full Text] [Related]
47. Isolation and characterization of Lactobacillus species having potential for use as probiotic cultures for dogs.
McCoy S; Gilliland SE
J Food Sci; 2007 Apr; 72(3):M94-7. PubMed ID: 17995807
[TBL] [Abstract][Full Text] [Related]
48. The characteristics of lactic acid bacteria isolated from fermented food as potential probiotics.
Fitriani VY; Suprapti B; Amin M
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):743-749. PubMed ID: 34214350
[TBL] [Abstract][Full Text] [Related]
49. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.
Keller MK; Hasslöf P; Stecksén-Blicks C; Twetman S
Acta Odontol Scand; 2011 Sep; 69(5):263-8. PubMed ID: 21306197
[TBL] [Abstract][Full Text] [Related]
50. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
Humphreys GJ; McBain AJ
Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138
[TBL] [Abstract][Full Text] [Related]
51. In vitro evaluation of anticancer effects of different probiotic strains on HCT-116 cell line.
Yenuganti VR; Yadala R; Azad R; Singh S; Chiluka V; Ahire J; Reddanna P
J Appl Microbiol; 2021 Oct; 131(4):1958-1969. PubMed ID: 33694215
[TBL] [Abstract][Full Text] [Related]
52. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
BMC Microbiol; 2021 Oct; 21(1):271. PubMed ID: 34615458
[TBL] [Abstract][Full Text] [Related]
53. In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
Wang Z; Wang L; Chen Z; Ma X; Yang X; Zhang J; Jiang Z
J Microbiol Biotechnol; 2016 Jun; 26(6):1018-25. PubMed ID: 26907754
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of oral intake of
Sharpe M; Shah V; Freire-Lizama T; Cates EC; McGrath K; David I; Cowan S; Letkeman J; Stewart-Wilson E
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1814-1821. PubMed ID: 31362572
[TBL] [Abstract][Full Text] [Related]
55. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
56. Biodetoxification of fungal mycotoxins zearalenone by engineered probiotic bacterium Lactobacillus reuteri with surface-displayed lactonohydrolase.
Liu F; Malaphan W; Xing F; Yu B
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8813-8824. PubMed ID: 31628520
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms.
Van Holm W; Carvalho R; Delanghe L; Eilers T; Zayed N; Mermans F; Bernaerts K; Boon N; Claes I; Lebeer S; Teughels W
NPJ Biofilms Microbiomes; 2023 Jan; 9(1):3. PubMed ID: 36681674
[TBL] [Abstract][Full Text] [Related]
58. Dental caries and microbiota in children with black stain and non-discoloured dental plaque.
Heinrich-Weltzien R; Bartsch B; Eick S
Caries Res; 2014; 48(2):118-25. PubMed ID: 24335143
[TBL] [Abstract][Full Text] [Related]
59. Characterization of oral lactobacilli as potential probiotics for oral health.
Kõll P; Mändar R; Marcotte H; Leibur E; Mikelsaar M; Hammarström L
Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
[TBL] [Abstract][Full Text] [Related]
60. Enhanced phagocytosis of Aggregatibacter actinomycetemcomitans cells by macrophages activated by a probiotic Lactobacillus strain.
Jaffar N; Okinaga T; Nishihara T; Maeda T
J Dairy Sci; 2018 Jul; 101(7):5789-5798. PubMed ID: 29680655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
